Public Engagement

See our upcoming events


Jenner Institute




The world's longest endurance event

Posted 26/07/2017

‘We started the first trial in 2002 and we finished the efficacy trial in 2013.’ Nine years of trials. That was on top of the time taken to develop the thing in the first place. That’s a long time. For Le Mans, the MdS and the Vendee Globe, the finish line is known, fixed; for vaccines, new data may move the finish line at any time. Vaccine development may not be as physically demanding, but to keep plugging away for twenty years surely requires mental resilience.

New grant for research to reduce use of primates in TB vaccine testing

Posted 26/07/2017

Jenner scientist Dr Rachel Tanner has been awarded an NC3Rs Skills and Knowledge Transfer Grant for the transfer of a novel non-human primate in vitro mycobacterial growth inhibition assay. The assay will be transferred to Public Health England and the Biomedical Primate Research Centre, with the aim of refining and reducing use of non-human primate TB infection models in the early evaluation of TB vaccine candidates.

News Archive

Recent Publications

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development. Tuberculosis (Edinb), 106, pp. 118-122. Article

Issues in vaccinology: Present challenges and future directions. Eur J Immunol. Article

Clinical Trials

Clinical trials are an essential part of vaccine development, and our volunteers play a critical role in our studies.

If you would like to find out more about paid clinical trials, and what is involved in participating, please go to our Recruiting Trials page to see which trials are currently recruiting.

Jenner Institute Podcasts

See all Jenner podcasts


All Seminars